<DOC>
	<DOCNO>NCT00106405</DOCNO>
	<brief_summary>Bipolar disorder affect 2.4 million adult USA age 18-65 considerable economic impact society . Bipolar mania account 1 7 psychiatric emergency associate significant morbidity mortality . The purpose study evaluate safety efficacy open-label memantine acute management adult bipolar I disorder hospitalize mania .</brief_summary>
	<brief_title>An Evaluation Safety Efficacy Memantine Patients With Acute Mania Associated With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Patients must document clinical diagnosis bipolar I disorder must currently experience manic mixed episode . Patients must voluntarily hospitalize primary diagnosis mania . Rapid cycle bipolar disorder . Suicidal risk . First manic episode . ECT , clozapine depot neuroleptic past 3 month . Substance dependence . Known HIV infection . Comorbid serious , uncontrolled systemic illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Bipolar I Disorder</keyword>
	<keyword>Mania</keyword>
	<keyword>Memantine HCl</keyword>
</DOC>